Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebocontrolled, phase 2 trial
Non-conventional
in English
| WHO COVID | ID: covidwho-655050
Search on Google
Collection:
Databases of international organizations
Database:
WHO COVID
Type of study:
Experimental Studies
/
Randomized controlled trials
Topics:
Vaccines
Language:
English
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS